Not exact matches
Breastfeeding can provide some
protection against flu for infants, including children younger
than 6 months who can not receive the flu
vaccine.
A well conducted study published in the Italian medical journals in June 2007 demonstrated that the daily intake of Colostrum can be 3x more effective
than the flu
vaccine for providing
protection.
Other recent research has shown that the number of antibodies needed to provide
protection is lower
than previously believed, possibly making a
vaccine easier to create.
Children ages six months to two years can receive an injectable flu
vaccine, but the nasal spray
vaccine is recommended in children between the ages of two and eight because it is believed to give better
protection than the shot.
But if the H3N2 strain in circulation differs substantially from the one used to make the
vaccine, the
vaccine may offer less
protection, and more people will get sick
than usual.
The method is much less cumbersome
than dealing with chicken eggs, and because the
vaccine is so easy to produce, the company intends to use 135 micrograms of hemagglutinin in each dose of
vaccine — 3 times higher
than current flu
vaccines — in hopes of getting better
protection.
«In less
than a year, our group and others have demonstrated that multiple
vaccine platforms can provide robust
protection against Zika virus challenge in animal models.
For one thing, cross-
protection from other viruses rarely offers more
than 70 %
protection, says Monath, as a
vaccine would.
The relatively low degree of
protection found in the Colombian trials might be partly explained, says Patarroyo, by problems with the formulation of the
vaccine at the time it was made, more
than two years ago.
In the study, mice given a lethal dose of dengue virus less
than a week after receiving the protective DMAb were completely protected from lethal disease — significantly more rapid
than vaccine - driven
protection, which can take weeks to months to reach peak efficacy levels.
Such models are valuable for the analysis of parameters associated with
vaccine safety, immunogenicity, delivery and
protection as NHPs replicate key features of the human immune response more faithfully
than any other animal model.
10 of 19 (53 %) placentas and 11 of 19 (58 %) fetal heads from mice who received Moderna's Zika mRNA
vaccine had viral RNA levels at the limit of detection of the assay, suggesting virtually complete
protection, and the remainder had substantially lower levels
than those detected in samples from mice in the placebo cohort.
The recent increase in cases of whooping cough among teenagers in the US suggests that the
protection conferred by the acellular Bordetella pertussis
vaccine (aP) that became standard in the mid 1990s is of shorter duration
than that conferred by the whole - bacteria formulation (wP) used since the 1950s.
Vaccines are used to offer protection against a number of diseases and so ensuring their effectiveness is important, and a study published in the journal Vaccine has reported that flu vaccines given in the morning brought about a greater immune (measured by antibody levels) response than those given in the af
Vaccines are used to offer
protection against a number of diseases and so ensuring their effectiveness is important, and a study published in the journal
Vaccine has reported that flu
vaccines given in the morning brought about a greater immune (measured by antibody levels) response than those given in the af
vaccines given in the morning brought about a greater immune (measured by antibody levels) response
than those given in the afternoon.
A new generation of Vi typhoid conjugate
vaccines (TCVs), licensed for use in young children and expected to provide longer lasting
protection than previous
vaccines, are now available.
Cats who are allowed to venture outdoors must have a different
vaccine and parasite
protection program
than those who remain indoors at all times.
A
vaccine is available but is not widely recommended because the disease is self - limiting and
protection is limited to no more
than six months following inoculation.
Tests show that Fel - O - Vax Lv - K provides better
protection than other FeLV
vaccines.
Notably, immunogenicity and
protection efficacy conferred by the NS1 mutant H3N8 CIVs was better
than that observed with a CIV H3N8 inactivated influenza
vaccine (IIV).
Moreover, a single intranasal immunization dose showed higher immunogenicity and
protection than that conferred with a commercial inactivated
vaccine, making our live - attenuated CIV an excellent
vaccine candidate for the prevention and control of CIV in dogs.
Research suggests the
vaccine may offer
protection for more
than three years, but most vets recommend a booster shot once a year to ensure your dog is safe, depending on local risk factors.
The nasal mist and oral
vaccine also provide
protection to the animal sooner
than the injection does.
The «localized immunity» the dog receives via the intranasal
vaccine appears to offer better
protection than the shot.
A dog who is vaccinated with this
vaccine receives well less
than one year of inadequate
protection but is placed at great risk for
vaccine - related illness.
They can be safely given to puppies much earlier
than vaccines and in fact the mother can be treated before giving birth thus giving her puppies
protection from the moment they are born.
These forms of the
vaccine tend to provide dogs
protection against kennel cough sooner
than the injected product.
There is not likely to be any harm other
than not getting adequate
protection from the
vaccine.
Some puppies can respond at an earlier age
than others; therefore start early and repeat the
vaccines to give
protection for all individuals as quickly as possible.
Bordetella: One intra-nasal
vaccine should be given no earlier
than 12 weeks of age to «at risk» dogs (those with active social contact, boarding, showing, or impaired respiratory function), with a booster being administered one year later then annually if risk of exposure or boarding (
protection generally lasts 6 - 12 months).
This allows local immunity to develop on the mucous membranes of the nose, throat, and windpipe where the infectious agents first attack and provides more rapid
protection against infection
than the injectable
vaccine.
Although the flu
vaccine isn't perfect, it's far better
than no
protection at all.